T1	Participants 270 346	40 patients with paroxysmal atrial fibrillation (AF) or atrial flutter (AFI)
T2	Participants 431 463	20 patients receiving flecainide
T3	Participants 565 596	patients treated with verapamil
T4	Participants 909 939	9 of 15 patients (60%) with AF
T5	Participants 963 994	23 of 32 patients (72%) with AF
T6	Participants 1289 1323	10 patients (26%) after flecainide
